Observation on the efficacy and safety of ferrous succinateon the treatment of iron deficiency anemia in pregnancy
Objective To investigate the efficacy and safety of ferrous succinate on the treatment of iron deficiency anemia in pregnancy. Methods 100 pregnant women with iron deficiency anemia in Deqing county people's hospital were selected as the subjects. The control group was treated with ferrous sulfate tablets, and the experimental group was treated with ferrous succinate, 3 tablets a day. RBC, HB levels, clinical efficacy and adverse reactions and other clinical indicators in the two groups were compared. Results The effective rate in the experimental group was 90%, which was significantly higher than that in the control group 74%, the difference was statistically significant (P<0.05). After treatment, Hb was (114.90±13.44) g / L, RBC was (3.87±0.82)×1012/L in the experimental group, while in the control group Hb was (102.91±10.52) g/L, RBC was (3.32±0.66)×1012/L, the differences had statistically significant (P<0.05). The adverse reaction rate in the experimental group was 6%, which was significantly lower than that in the control group 22%, the difference was statistically significant (P<0.05). Conclusion Ferrous succinate efficacy in the treatment of pregnant women with iron deficiency anemia is ideal, high safety, mild adverse reactions.
NETL
NSTL
万方数据
维普
